This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through November 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
utilities: Archive
Can PPL's Expanded Investment Plan Accelerate Long-Term Growth?
by Zacks Equity Research
PPL's $25 billion investment plan targets grid upgrades, new power generation and 10% annual rate-base growth, supporting 7-9% earnings growth through 2030.
PPLNegative Net Change AEPPositive Net Change LNTPositive Net Change
utilities
NRG Q3 Earnings Call Focuses on Asset Sale and 2027 Outlook
by Zacks Equity Research
NRG unveils a $4 billion asset sale, expands share buybacks to $3 billion and sets 2027 earnings targets while advancing a major Texas data-center power project.
NRGNegative Net Change
earnings utilities
AI Boom Fuels Southern Company's Data Center Power Usage Growth
by Zacks Equity Research
SO's data center electricity usage surges 59% in Q3 2026, backed by 21 GW of signed contracts, fueling growth and major capital investment plans.
SONegative Net Change DUKPositive Net Change AEPPositive Net Change DNegative Net Change
artificial-intelligence energy utilities
VST Q3 Earnings Beat on Strong Power Pricing, Revenues Rise Y/Y
by Zacks Equity Research
Vistra's Q3 earnings surge 84.6% on stronger power pricing and retail margins, while revenues climb 27.7%, prompting higher 2026 EBITDA guidance.
VSTNegative Net Change FENegative Net Change IDANegative Net Change EVRGNegative Net Change
utilities
Vistra Q3 Earnings Call Highlights Cash Flow Plans & Demand Risks
by Zacks Equity Research
VST raises its 2026 outlook and projects stronger cash flow per share through 2030, backed by Cogentrix, power contracts and buybacks despite demand risks.
VSTNegative Net Change
earnings utilities
Can Moderna's First Cancer Therapy Win FDA Approval in 2027?
by Sundeep Ganoria
MRNA targets a year-end 2026 FDA filing for its personalized cancer therapy, intismeran, potentially paving the way for a regulatory decision in 2027.
MRNANegative Net Change SNYPositive Net Change PFENegative Net Change MRKPositive Net Change
biotechs medical messenger-rna pharmaceuticals utilities
Genie Energy Stock Gains 3.7% as Q3 Earnings Increase Y/Y
by Zacks Equity Research
GNE's Q3 earnings surge y/y on stronger margins and improved profitability despite lower revenues, customer losses and higher acquisition costs.
GNENegative Net Change
earnings utilities
NRG Energy Q3 Earnings Beat Estimates on LS Power Asset Gains
by Zacks Equity Research
NRG Energy's Q3 earnings surge 68.3%, fueled by LS Power assets and stronger margins, as it unveils a $4 billion asset sale and issues the 2027 outlook.
NRGNegative Net Change PCGNegative Net Change CMSPositive Net Change IDANegative Net Change
earnings utilities
PPL Q3 Earnings Call Highlights Higher Growth and Data Center Demand
by Zacks Equity Research
PPL raises its long-term earnings growth target to 7-9%, backed by a $25 billion capital plan and rising data center demand in Pennsylvania and Kentucky.
PPLNegative Net Change
earnings utilities
Renewable Energy & Battery Stocks to Buy as Blue Wave Sweeps US Congress
by Aparajita Dutta
A Democratic takeover of Congress could boost clean energy policy support, while rising AI power demand creates opportunities for four stocks.
PPLNegative Net Change GNRCNegative Net Change BENegative Net Change CWENNegative Net Change
artificial-intelligence batteries energy utilities